Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abel Russ

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Environmental Health Perspectives|September 6, 2005
Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individualsGary Ginsberg, Dale Hattis, Abel Russ, et al.
Journal of Toxicology and Environmental Health. Part A|January 10, 2004
Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agentsGary Ginsberg, Dale Hattis, Abel Russ, et al.
Journal of Toxicology and Environmental Health. Part A|December 1, 2007
Approaches to acrylamide physiologically based toxicokinetic modeling for exploring child-adult dosimetry differencesKatherine Walker, Dale Hattis, Abel Russ, et al.
Environmental Health Perspectives|August 4, 2004
Age-related differences in susceptibility to carcinogenesis: a quantitative analysis of empirical animal bioassay dataDale Hattis, Robert Goble, Abel Russ, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 15, 2003
Differences in pharmacokinetics between children and adults--II. Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modelingDale Hattis, Gary Ginsberg, Bob Sonawane, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 16, 2002
Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literatureGary Ginsberg, Dale Hattis, Babasaheb Sonawane, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Environmental Health Perspectives|September 6, 2005
Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individualsGary Ginsberg, Dale Hattis, Abel Russ, et al.
Journal of Toxicology and Environmental Health. Part A|January 10, 2004
Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agentsGary Ginsberg, Dale Hattis, Abel Russ, et al.
Journal of Toxicology and Environmental Health. Part A|December 1, 2007
Approaches to acrylamide physiologically based toxicokinetic modeling for exploring child-adult dosimetry differencesKatherine Walker, Dale Hattis, Abel Russ, et al.
Environmental Health Perspectives|August 4, 2004
Age-related differences in susceptibility to carcinogenesis: a quantitative analysis of empirical animal bioassay dataDale Hattis, Robert Goble, Abel Russ, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 15, 2003
Differences in pharmacokinetics between children and adults--II. Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modelingDale Hattis, Gary Ginsberg, Bob Sonawane, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 16, 2002
Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literatureGary Ginsberg, Dale Hattis, Babasaheb Sonawane, et al.
Pageof 1